: Key Takeaways: In a significant stride towards revolutionizing biomedical research, CryoLogyx, a pioneering spinout from the University of Warwick, has successfully concluded a £500k seed funding round. This funding, spearheaded by private UK business angels and the Wider Oxford Technology Angel Network (WOTAN), marks a crucial milestone in the advancement of cryopreserved celltechnology. Let’s delve into the details of this groundbreaking development and its implications for the future of life sciences. CryoLogyx: Redefining CellTechnology Founded in 2020 by CEO Dr. Tom Congdon and CSO Prof. Matt Gibson, CryoLogyx emerges as a frontrunner in the realm of cryopreservation, offering The post Breakthrough Funding Fuels Innovation in Cryopreservation: What You Need to Know appeared first on Business Today